期刊文献+

食管癌高发区人群Bcl-2基因多态性与贲门癌及癌前病变易感性研究 被引量:3

Research on genetic susceptibility of Bcl-2 gene polymorphism to gastric cardiac carcinoma and precancerous lesions in population with high incidence of esophageal cancer
原文传递
导出
摘要 目的 Bcl-2作为一种癌基因,与肿瘤早期形成密切相关。本研究旨在探讨凋亡抑制基因Bcl-2启动子区-938(C/A)位点单核苷酸多态性(single nucleotide polymorphism,SNP)与河北省南部高发区人群贲门腺癌及其癌前病变遗传易感性的相关性。方法采用病例对照研究方法,选取2007-12-01-2009-12-30河北省南部食管癌高发区人群195名正常对照者、92例贲门癌前病变患者和169例贲门癌患者组织标本进行研究,应用UNIQ-10柱式动物基因组DNA抽提试剂盒进行组织DNA提取,并通过聚合酶链式反应-限制性片段长度多态性分析(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)方法检测Bcl-2-938位点基因型,随机选取不同基因型的标本进行DNA测序,分析该位点多态性与贲门癌及癌前病变的遗传易感性关系。结果 Bcl-2启动子区-938位点CC基因型频率分别为48.5%、47.8%和33.8%,差异有统计学意义,均P<0.05。携带CC基因型的个体与AA基因型相比,贲门癌(P=0.009)与癌前病变(P=0.020)的发病风险增加,经性别、年龄、吸烟和家族史校正后的OR值分别为2.564(95%CI=1.268~5.184)和2.810(95%CI=1.179~6.639)。贲门癌患者组吸烟者比例为56.8%,高于癌前病变组的43.5%和对照组的34.4%,差异有统计学意义,χ^2=18.446,P<0.001;而吸烟阳性组中与AA基因型相比,携带CC基因型(P=0.020)可增加贲门癌的发病风险,经性别、年龄、家族史和饮酒校正后的OR值为3.635(95%CI=1.226~10.777)。结论 Bcl-2-938位点CC基因型可显著增加河北省食管癌高发区人群贲门癌及癌前病变的遗传易感性和发病风险。 OBJECTIVE As a oncogene,Bcl-2 is closely related to the early formation of tumor.This study aimed to investigate the association of single nucleotide polymorphisms(SNP)in transcription start site-938(C/A)on apoptosis-inhibiting gene Bcl-2 with genetic susceptibility of patients with gastric cardiac adenocarcinoma and precancerous lesions in the high-risk areas,south of Hebei Province,China.METHODS From December 1,2007 to December 30,2009,tissue samples were collected from 195 cases healthy controls,92 cases of cardia precancerous lesions and 169 cases of gastric cardiac adenocarcinoma in Southern of Hebei Province.The DNA samples were extracted from different tissues,and the UNIQ-10 Column animal genome isolation kit was used to extract tissue DNA and polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP)analysis was adopted to detect the genotype of Bcl-2.Samples with different genotypes were randomly selected for DNA sequencing to analyze the relationship between polymorphism of this site and genetic susceptibility to cardiac cancer and precancerous lesions.RESULTS The frequencies of CC genotype at site-938 in Bcl-2 promoter were 48.5%,47.8% and 33.8%,respectively,and the difference was statistically significant(P<0.05)Compared with AA genotype,the risk of cardiac cancer(P=0.009)and precancerous lesions(P=0.020)was increased in individuals with CC genotype.Adjusted by sex,age,smoking and family history,ORvalues were 2.564(95%CI=1.268-5.184)and 2.810(95%CI=1.179-6.639),respectively.The proportion of smokers in patients with cardiac cancer was56.8%,higher than 43.5%in patients with precancerous lesions and 34.4%in the control group,and the difference was statistically significant,χ^2=18.446,P<0.001.Compared with AA genotype,CC genotype(P=0.020)in smoking positive group increased the risk of cardiac cancer.The ORvalue adjusted by sex,age,family history and drinking was 3.635(95%CI=1.226-10.777).CONCLUSION CC genotype in Bcl-2-938(C/A)SNP can significantly increase the risk of gastric cardiac adenocarcinoma and precancerous lesions at high-risk areas of esophageal cancer in China.
作者 袁丽 张立玮 尔丽绵 郭硕 徐志彬 曹玉 曹颖 YUAN Li;ZHANG Li-wei;ER Li-mian;GUO Shuo;XU Zhi-bin;CAO Yu;CAO Ying(Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,P.R.China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2019年第22期1669-1674,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 国家重点研发计划(2016YFC1302800 2016YFC0901400)
关键词 贲门癌 癌前病变 基因多态性 BCL-2基因 遗传易感性 gastric cardiac adenocarcinoma precancerous lesions gene polymorphism Bcl-2gene genetic susceptibility
  • 相关文献

参考文献7

二级参考文献48

  • 1陈志峰.WHO肿瘤新分类与食管癌高发区变化的思考[J].中国肿瘤临床,2005,32(21):1201-1203. 被引量:27
  • 2张立玮,温登瑰,王士杰,李英赛,于卫芳,王晓玲,王俊和,李素平,李永伟,王顺平,尔立绵,丛庆文,马彩芬.食管癌高发区贲门癌、胃癌流行强度分析及其对内镜筛查的启示[J].肿瘤防治研究,2005,32(12):792-795. 被引量:34
  • 3张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 4张立玮,温登瑰,李英赛,于卫芳,王顺平,尔立绵,丛庆文,王俊和,李素平,李永伟,马彩芬,单宝恩,王士杰.EPIDEMIC STRENGTH OF CARDIA AND DISTANT STOMACH CANCER IN THE HIGH RISK REGION OF ESOPHAGEAL CANCER AND THEIR IMPLICATION TO EDOSCOPIC SCREENING[J].Chinese Journal of Cancer Research,2006,18(2):111-115. 被引量:11
  • 5Hamiltion SR, Aahonen LA. Pathology and genetics of tumours of the digestive system [M]. Lyon, France: IARC Press, 2000. 11-36.
  • 6LEHNERDT G F, FRANZ P, BANKFALVI A, et al. The regulatory BCL2 promoter polymorphism ( -938C > A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma[ J]. Ann Oncol,2009,20 (6) : 1094-1099.
  • 7KIDD L R, COULIBALY A,TEMPLTON T M, et al. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer [ J ]. Prostate Cancer Prostatic Dis,2006, 9 ( 3 ) :284-292.
  • 8HIRATA H, HINODA Y, NAKAJIMA K,et al. The Bc12-938CC genotype has poor prognosis and lower survival in renal cancer [ J ]. J Urol,2009,182(2) :721-727.
  • 9CALLAGY G M, WEBBER M J, PHAROAH P D, et al. Meta- analysis confirms BCL2 is an independent prognostic marker in breast cancer [ J ]. BMC Cancer,2008,29 ( 8 ) : 153.
  • 10BACHMANN H S, OTTERBACH F, CALTIES R,et al. The AA genotype of the regulatory Bcl-2 promoter polymorphism( -938C > A) is associated with a favorable outcome in lymph node-negative invasive breast cancer patients [ J ]. Clin Cancer Res, 2007, 13 ( 19 ) :5790-5797.

共引文献81

同被引文献51

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部